Compare $ATOS vs $JSPR | Chartloom

Compare

$ATOS vs $JSPR

Atossa Therapeutics Inc · Jasper Therapeutics Inc

ATOS

Atossa Therapeutics Inc

JSPR

Jasper Therapeutics Inc

Compare $ATOS vs $JSPR

Comparing Atossa Therapeutics Inc and Jasper Therapeutics Inc

ATOSAtossa Therapeutics Inc

JSPRJasper Therapeutics Inc

ATOSAtossa Therapeutics Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.2%

52W performance

-85.3%

FCF yield

-147.1%

JSPRJasper Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.0%

52W performance

-76.2%

FCF yield

-318.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATOS

JSPR

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ATOS$24M

JSPR$19M

Enterprise Value

ATOS$-2M

JSPR$12M

Price

ATOS$2.44

JSPR$0.57

P/E Ratio

ATOSN/A

JSPRN/A

P/S Ratio

ATOS145.95x

JSPR0.00x

EV/Sales

ATOS-17.14x

JSPR0.00x

EV/EBITDA

ATOS0.00x

JSPR0.00x

P/B Ratio

ATOS0.87x

JSPR13.31x

P/FCF Ratio

ATOSN/A

JSPRN/A

EV/FCF

ATOS0.05x

JSPR-0.19x

PEG Ratio

ATOSN/A

JSPRN/A

Forward P/E (NTM)

ATOSN/A

JSPRN/A

Forward P/S (NTM)

ATOSN/A

JSPRN/A

Revenue (TTM)

ATOS$0

JSPR$0

Revenue Growth (YoY)

ATOSN/A

JSPRN/A

Forward Rev Growth

ATOS184.1%

JSPR-81.1%

Gross Margin (TTM)

ATOS62.5%

JSPR0.0%

Operating Margin (TTM)

ATOS0.0%

JSPR0.0%

EBITDA Margin (TTM)

ATOS0.0%

JSPR0.0%

Net Margin (TTM)

ATOS0.0%

JSPR0.0%

FCF Margin (TTM)

ATOSN/A

JSPRN/A

Net Income (TTM)

ATOS$-38M

JSPR$-32M

FCF (TTM)

ATOS$-36M

JSPR$-60M

EPS (TTM)

ATOS-$4.23

JSPR-$1.11

ROE (TTM)

ATOS-10299.0%

JSPR-61887.0%

ROA (TTM)

ATOS-8578.0%

JSPR-10067.0%

ROIC (TTM)

ATOS-10299.0%

JSPR-61887.0%

Cash

ATOS$26M

JSPR$7M

Debt

ATOS$0

JSPR$0

Net Cash/Debt

ATOS$26M

JSPR$7M

Current Ratio (TTM)

ATOS5.69x

JSPR1.48x

Quick Ratio (TTM)

ATOS4.81x

JSPR1.02x

Debt/Equity (TTM)

ATOS0.00x

JSPR0.00x

Debt/Assets (TTM)

ATOS0.0%

JSPR0.0%

Interest Coverage (TTM)

ATOSN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

JSPR0.00x

Beta

ATOS1.39

JSPR3.37

52W Performance

ATOS-85.3%

JSPR-76.2%

YTD Performance

ATOS-74.2%

JSPR-69.0%

% from 52W High

ATOS-87.4%

JSPR-78.8%

% from 52W Low

ATOS43.5%

JSPR81.0%

Asset Turnover (TTM)

ATOS0.01x

JSPR0.00x

FCF Yield (TTM)

ATOS-147.1%

JSPR-318.0%

Earnings Yield (TTM)

ATOS-155.0%

JSPR-167.5%

Dividend Yield (TTM)

ATOSN/A

JSPRN/A

Rule of 40

ATOS0.0

JSPR0.0

EV/GP/RG

ATOSN/A

JSPRN/A

Ticker research

View ATOS research View JSPR research

Metric	ATOS Atossa Therapeutics Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$24M	$19M
Enterprise Value	$-2M	$12M
Price	$2.44	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	0.00x
EV/Sales	-17.14x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	184.1%	-81.1%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-32M
FCF (TTM)	$-36M	$-60M
EPS (TTM)	-$4.23	-$1.11
ROE (TTM)	-10299.0%	-61887.0%
ROA (TTM)	-8578.0%	-10067.0%
ROIC (TTM)	-10299.0%	-61887.0%
Financial Health
Cash	$26M	$7M
Debt	$0	$0
Net Cash/Debt	$26M	$7M
Current Ratio (TTM)	5.69x	1.48x
Quick Ratio (TTM)	4.81x	1.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	3.37
52W Performance	-85.3%	-76.2%
YTD Performance	-74.2%	-69.0%
% from 52W High	-87.4%	-78.8%
% from 52W Low	43.5%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-147.1%	-318.0%
Earnings Yield (TTM)	-155.0%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View JSPR research

Valuation

P/S Ratio

JSPR

0.00x

ATOS

145.95x

EV/FCF

JSPR

-0.19x

ATOS

0.05x

Growth & revenue

Forward Revenue Growth

ATOS

184.1%

JSPR

-81.1%

Profitability & performance

Gross Margin

ATOS

62.5%

JSPR

0.0%

ROE

ATOS

-10299.0%

JSPR

-61887.0%

FCF Yield %

ATOS

-147.1%

JSPR

-318.0%

52-Week Performance

JSPR

-76.2%

ATOS

-85.3%

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ATOS$24M

JSPR$19M

Enterprise Value

ATOS$-2M

JSPR$12M

Price

ATOS$2.44

JSPR$0.57

P/E Ratio

ATOSN/A

JSPRN/A

P/S Ratio

ATOS145.95x

JSPR0.00x

EV/Sales

ATOS-17.14x

JSPR0.00x

EV/EBITDA

ATOS0.00x

JSPR0.00x

P/B Ratio

ATOS0.87x

JSPR13.31x

P/FCF Ratio

ATOSN/A

JSPRN/A

EV/FCF

ATOS0.05x

JSPR-0.19x

PEG Ratio

ATOSN/A

JSPRN/A

Forward P/E (NTM)

ATOSN/A

JSPRN/A

Forward P/S (NTM)

ATOSN/A

JSPRN/A

Revenue (TTM)

ATOS$0

JSPR$0

Revenue Growth (YoY)

ATOSN/A

JSPRN/A

Forward Rev Growth

ATOS184.1%

JSPR-81.1%

Gross Margin (TTM)

ATOS62.5%

JSPR0.0%

Operating Margin (TTM)

ATOS0.0%

JSPR0.0%

EBITDA Margin (TTM)

ATOS0.0%

JSPR0.0%

Net Margin (TTM)

ATOS0.0%

JSPR0.0%

FCF Margin (TTM)

ATOSN/A

JSPRN/A

Net Income (TTM)

ATOS$-38M

JSPR$-32M

FCF (TTM)

ATOS$-36M

JSPR$-60M

EPS (TTM)

ATOS-$4.23

JSPR-$1.11

ROE (TTM)

ATOS-10299.0%

JSPR-61887.0%

ROA (TTM)

ATOS-8578.0%

JSPR-10067.0%

ROIC (TTM)

ATOS-10299.0%

JSPR-61887.0%

Cash

ATOS$26M

JSPR$7M

Debt

ATOS$0

JSPR$0

Net Cash/Debt

ATOS$26M

JSPR$7M

Current Ratio (TTM)

ATOS5.69x

JSPR1.48x

Quick Ratio (TTM)

ATOS4.81x

JSPR1.02x

Debt/Equity (TTM)

ATOS0.00x

JSPR0.00x

Debt/Assets (TTM)

ATOS0.0%

JSPR0.0%

Interest Coverage (TTM)

ATOSN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

JSPR0.00x

Beta

ATOS1.39

JSPR3.37

52W Performance

ATOS-85.3%

JSPR-76.2%

YTD Performance

ATOS-74.2%

JSPR-69.0%

% from 52W High

ATOS-87.4%

JSPR-78.8%

% from 52W Low

ATOS43.5%

JSPR81.0%

Asset Turnover (TTM)

ATOS0.01x

JSPR0.00x

FCF Yield (TTM)

ATOS-147.1%

JSPR-318.0%

Earnings Yield (TTM)

ATOS-155.0%

JSPR-167.5%

Dividend Yield (TTM)

ATOSN/A

JSPRN/A

Rule of 40

ATOS0.0

JSPR0.0

EV/GP/RG

ATOSN/A

JSPRN/A

Ticker research

View ATOS research View JSPR research

Metric	ATOS Atossa Therapeutics Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$24M	$19M
Enterprise Value	$-2M	$12M
Price	$2.44	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	0.00x
EV/Sales	-17.14x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	184.1%	-81.1%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-32M
FCF (TTM)	$-36M	$-60M
EPS (TTM)	-$4.23	-$1.11
ROE (TTM)	-10299.0%	-61887.0%
ROA (TTM)	-8578.0%	-10067.0%
ROIC (TTM)	-10299.0%	-61887.0%
Financial Health
Cash	$26M	$7M
Debt	$0	$0
Net Cash/Debt	$26M	$7M
Current Ratio (TTM)	5.69x	1.48x
Quick Ratio (TTM)	4.81x	1.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	3.37
52W Performance	-85.3%	-76.2%
YTD Performance	-74.2%	-69.0%
% from 52W High	-87.4%	-78.8%
% from 52W Low	43.5%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-147.1%	-318.0%
Earnings Yield (TTM)	-155.0%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View JSPR research